Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,323,256
+$310,483 QoQ
Shares Held
15,533
+1.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#246
of 477 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $22,827,015 across 21 Biotechnology names. CYTK ranks #9 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,887 | $2,678,471 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,938 | $2,452,852 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,691 | $2,301,486 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
5,658 | $1,788,437 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
49,246 | $1,742,815 | |
| 6 | EXEL |
Exelixis, Inc.
|
30,229 | $1,644,759 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,605 | $1,398,754 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
4,647 | $1,324,255 |
All Filings in CYTK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,323,256 | 15,533 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,012,773 | 15,366 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $933,783 | 14,696 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $508,270 | 9,248 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $442,612 | 11,013 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $173,248 | 3,683 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $192,825 | 3,652 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $183,182 | 3,381 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $283,875 | 4,049 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $272,845 | 3,268 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $87,820 | 2,981 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $53,855 | 1,651 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $52,925 | 1,504 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $97,688 | 2,132 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $94,913 | 1,959 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $14,262 | 363 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $4,785 | 130 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $3,053 | 67 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $2,394 | 67 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,128 | 57 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,325 | 57 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,184 | 57 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,363 | 63 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,343 | 57 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||